Abstract 【Objective】To explore the changes of inflammatory factors, renal function and febuxostat treatment in male patients with gout and hyperuricemia (HUA). 【Methods】A total of 90 patients with hyperuricemia who were diagnosed and met the criteria in our hospital were selected from April. 2017 to May. 2018. According to the presence of gout, patients were divided into the gout group(n=45) and the non-gout group(n=45). Meanwhile, a total of 45 healthy volunteers who had physical examinations at the same time period were selected as the healthy control group. The changes of inflammatory factors [Hypersensitivity reaction protein (hs-CRP), Interleukin-6 (IL-6)] and renal function [Blood urea nitrogen (BUN), Serum creatinine (SCr), Blood uric acid (SUA), Glomerular filtration rate(eGFR)] were compared among the three groups. The gout group was treated with febuxostat, and the changes of inflammatory factors and renal function were compared before and after three month treatment. 【Results】Levels of hs-CRP, IL-6, SCr, SUA, and eGFR showed statistically significant difference among three groups(P<0.05). However, there were no significant differences in BUN level(P>0.05). Significant differences in SCr, SUA, and eGFR were shown between the gout group and the control group(P<0.05)and there was significant difference of SUA level between the non-gout group and healthy control group(P<0.05). After treatment, the serum levels of hs-CRP, IL-6 and SUA in the gout group were significantly lower than those before treatment and the differences were statistically significant(P<0.05). However,the changes of BUN, SCr and eGFR were not significantly different (P>0.05). 【Conclusion】The serum levels of hs-CRP, IL-6, SCr, SUA,and eGFR were significantly increased in male patients with gout complicated with hyperuricemia. The application of febuxostat can reduce the level of SUA. The clinical efficacy was satisfactory and it is worthy of clinical promotion.
LI Yong-gang. Changes of Inflammatory Factors and Renal Function with Febuxostat Treatment in Male Patients of Gout Complicated with Hyperuricemia[J]. JOURNAL OF CLINICAL RESEARCH, 2018, 35(11): 2124-2126.
2018, Vol. 35 
